MAIA Biotechnology Inc. (MAIA)
MAIA Biotechnology Opens Enrollment for Phase 2 Expansion Trial of Novel Telomere-Targeting Agent at Winship Cancer Institute of Emory University
MAIA Biotechnology Opens Enrollment for Phase 2 Expansion Trial of Novel Telomere-Targeting Agent at Winship Cancer Institute of Emory University
Stable Commits U.S. $100M to Zenzic Capitals Evergreen Credit Strategy as the Firm Continues its Institutional Expansion
Lite Strategy Leads Strategic Investment in LitVM
Fusemachines Expands Access to Agentic AI for Talent Acquisition Through Broad ATS Connectivity
Exyn Technologies to Participate in the iAccess Alpha Virtual Best Ideas Summer Investment Conference 2026 on June 23–24, 2026
Earth Science Tech, Inc. Reports Fiscal Year-End Financial Results for March 31, 2026
NewGen Increases K25.ai Ownership to 10% in Closed Pre-A Round at US$100 Million Valuation with Total US$10 Million Invested
Nightfood Holdings Inc. (OTCQB: NGTF) Builds AI-Driven Automation Tools for Hospitality, Pharmaceutical, Lab and Industrial Spaces
Quoin Pharmaceuticals Completes Establishment of Japanese Subsidiary to Advance Commercial Readiness for QRX003
LIXTE Biotechnology Provides Update on NOMAD Acquisition; Transaction Expected to Close On or About July 1, 2026